Answers are grounded in this paper and cite their sources.
The emergence and spread of extended-spectrum beta-lactamases (ESBLs) in Gram-negative bacteria pose important challenges for clinicians, as management options for these organisms are limited. The emergence of ESBL-producing Gram-negative bacteria is one of the most significant epidemiologic changes in infectious diseases during recent years. Failure to treat with an antibiotic active against ESBL-producing organisms is associated with increased patient morbidity and mortality. Carbapenems are considered the primary antibacterials for infections caused by ESBL-producing organisms but their overuse poses significant cause for concern.
No takes yet. Share an insight, caveat, or question.
S. Scott Sutton (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: